Evidence map›Paper›PMID 19540203›Full record

ReviewBiochemical and biophysical research communications2009

Role of specific microRNAs for endothelial function and angiogenesis.

Fusheng Wu, Zeran Yang, Guohong Li

Abstract readReview
In one paragraph

Review in Biochemical and biophysical research communications, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Fusheng WuDepartment of Neurosurgery & Physiology, LSU Health Science Center, Shreveport, LA 71130, USA.
Zeran Yang
Guohong Li
Zhejiang University · CNLouisiana State University Health Sciences Center Shreveport · US

Funding

Mechanisms of CD40/CD40L in vascular injury and repairR01HL087990 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI LI, GUOHONG · 2008 to 2013
$1.6M
NHLBI NIH HHS HL087990NHLBI NIH HHS R01 HL087990
6 · The paper itself

Abstract

Accumulating evidence indicates that various aspects of angiogenesis, such as proliferation, migration, and morphogenesis of endothelial cells, can be regulated by specific miRNAs in an endothelial-specific manner. As novel molecular targets, miRNAs have a potential value for treatment of angiogenesis-associated diseases such as cancers, inflammation, and vascular diseases. In this article, we review the latest advances in the identification and validation of angiogenesis-regulatory miRNAs and their targets, and discuss their roles and mechanisms in regulating endothelial cell function and angiogenesis.

Indexed as

Neovascularization, PhysiologicAnimalsEndothelium, VascularGene Expression RegulationHumansMiceMicroRNAsRibonuclease IIIMicroRNAsRibonuclease III

Identifiers

PMID19540203
PMCPMC2821898
OpenAlexW2153401001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.